CoChat

Microbiota-Derived Short-Chain Fatty Acids Promote LAMTOR2-Mediated Immune Responses in Macrophages

Open access
Wu, Ting, Li, Hongru, Su, Cong, Xu, Fangming, Yang, Guangwei, Sun, Kaili, Xu, Mengran, Lv, Na, Meng, Bao, Liu, Yanyan, Hu, Lifen, Liu, Yan, Gao, Yufeng, Wang, Heng, Lan, Yanhu, Xu, Dexiang, Li, Jiabin · 2020 · mSystems

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Abstract

These observations highlight that SCFAs promote macrophage elimination of K. pneumoniae via a LAMTOR2-dependent signal pathway and suggest that it is possible to intervene in K. pneumoniae pneumonia by targeting the gut microbiota.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/msystems.00587-20

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG 1 Gut microbiota depletion exacerbates K. pneumoniae-induced lung injury. (a) Pulmonary bacterial burdens in antibiotic-treated and untreated controls 12 h and 24 h after intranasal challenge with 1 × 105 CFU of K. pneumoniae. (b) Survival rates of antibiotic-treated and untreated controls infected by K. pneumoniae. (c) Representative hematoxylin and eosin (H&E) staining and quantification of pathological scores of lung sections derived from antibiotic-treated and untreated controls after K. pneumoniae infection. Scale bars, 50 μm. (d) Phagocytic capacity of isolated alveolar macrophages from antibiotic-treated and untreated controls after K. pneumoniae infection evaluated by flow cytometry (MOI = 100). (e) Bacterial loads of isolated alveolar macrophages from antibiotic-treated and untreated controls. Data are from three independent experiments (a, b, d, e) or one experiment representative of three independent experiments (c) (means ± SEM). The group size was 8 to 12 mice. The P values were determined using two-tailed Student t tests (a, c to e) or the log rank (Mantel-Cox) test (b). *, P < 0.05; **, P < 0.01; ***, P < 0.001. FITC-A, fluorescein isothiocyanate-area; NS, not significant. AT, antibiotic-treated mice.
FIG 1 Gut microbiota depletion exacerbates K. pneumoniae-induced lung injury. (a) Pulmonary bacterial burdens in antibiotic-treated and untreated controls 12 h and 24 h after intranasal challenge with 1 × 105 CFU of K. pneumoniae. (b) Survival rates of antibiotic-treated and untreated controls infected by K. pneumoniae. (c) Representative hematoxylin and eosin (H&E) staining and quantification of pathological scores of lung sections derived from antibiotic-treated and untreated controls after K. pneumoniae infection. Scale bars, 50 μm. (d) Phagocytic capacity of isolated alveolar macrophages from antibiotic-treated and untreated controls after K. pneumoniae infection evaluated by flow cytometry (MOI = 100). (e) Bacterial loads of isolated alveolar macrophages from antibiotic-treated and untreated controls. Data are from three independent experiments (a, b, d, e) or one experiment representative of three independent experiments (c) (means ± SEM). The group size was 8 to 12 mice. The P values were determined using two-tailed Student t tests (a, c to e) or the log rank (Mantel-Cox) test (b). *, P < 0.05; **, P < 0.01; ***, P < 0.001. FITC-A, fluorescein isothiocyanate-area; NS, not significant. AT, antibiotic-treated mice.CC BY · PubMed Central
FIG 2 Gut microbiota depletion alters profiles of cecum metabolomics and associated gut microbiomes. (a) Hierarchical clustering heatmap of metabolites identified in cecum contents from antibiotic-treated and untreated controls. Red denotes increased expression; green denotes decreased expression. (b) Selected examples of KEGG pathway enrichment. Disturbances in SCFA metabolism are highlighted in red. (c) α-Diversity (Shannon index) and β-diversity (Bray-Curtis similarity index) of 16S rRNA genes from antibiotic-treated and untreated controls. (d) Discriminative operational taxonomic unit (OTU) abundances of taxonomic distributions at the phylum and genus levels in antibiotic-treated compared to untreated controls. (e) Spearman’s rank correlation between cecum metabolites and associated gut microbiota in antibiotic-treated and untreated controls. Red connections indicate a positive correlation, while blue connections are negative. The P values were determined using the hypergeometric test and the Benjamini-Hochberg false-discovery rate (FDR) correction (b) or the two-tailed Wilcoxon rank sum test (e). *, P < 0.05; **, P < 0.01; ***, P < 0.001. AT, antibiotic-treated mice.
FIG 2 Gut microbiota depletion alters profiles of cecum metabolomics and associated gut microbiomes. (a) Hierarchical clustering heatmap of metabolites identified in cecum contents from antibiotic-treated and untreated controls. Red denotes increased expression; green denotes decreased expression. (b) Selected examples of KEGG pathway enrichment. Disturbances in SCFA metabolism are highlighted in red. (c) α-Diversity (Shannon index) and β-diversity (Bray-Curtis similarity index) of 16S rRNA genes from antibiotic-treated and untreated controls. (d) Discriminative operational taxonomic unit (OTU) abundances of taxonomic distributions at the phylum and genus levels in antibiotic-treated compared to untreated controls. (e) Spearman’s rank correlation between cecum metabolites and associated gut microbiota in antibiotic-treated and untreated controls. Red connections indicate a positive correlation, while blue connections are negative. The P values were determined using the hypergeometric test and the Benjamini-Hochberg false-discovery rate (FDR) correction (b) or the two-tailed Wilcoxon rank sum test (e). *, P < 0.05; **, P < 0.01; ***, P < 0.001. AT, antibiotic-treated mice.CC BY · PubMed Central
FIG 3 SCFAs promote inflammatory responses during K. pneumoniae-induced sepsis. (a) Survival rates of SCFA-treated mice and untreated controls postinfection with 1 × 105 CFU of K. pneumoniae. (b) Lung and blood bacterial burdens in SCFA-treated mice and untreated controls 12 h and 24 h after K. pneumoniae infection. (c) Representative H&E staining and quantification of pathological scores of lung sections from SCFA-treated mice and untreated controls 12 h after K. pneumoniae infection. Scale bars, 50 μm. (d) Phagocytic capacity of isolated alveolar macrophages from SCFA-treated mice and untreated controls. (e) Bacterial loads of isolated alveolar macrophages from SCFA-treated mice and untreated controls. (f, g) Phagocytosis (f) and clearance (g) of SCFA-treated differentiated THP-1 cells and untreated controls after K. pneumoniae infection. (h) Survival rates of antibiotic-treated mice treated with SCFAs or vehicle. (i) Pulmonary bacterial burdens in antibiotic-treated mice treated with SCFAs or vehicle. The group size was 8 to 12 mice. Data are from three independent experiments (b, d to g, i) or one experiment representative of three independent experiments (a, c, h) (means ± SEM). The P values were determined using a log rank (Mantel-Cox) test (a, h) or two-tailed Student t tests (b to g, i). *, P < 0.05; **, P < 0.01; ***, P < 0.001.
FIG 3 SCFAs promote inflammatory responses during K. pneumoniae-induced sepsis. (a) Survival rates of SCFA-treated mice and untreated controls postinfection with 1 × 105 CFU of K. pneumoniae. (b) Lung and blood bacterial burdens in SCFA-treated mice and untreated controls 12 h and 24 h after K. pneumoniae infection. (c) Representative H&E staining and quantification of pathological scores of lung sections from SCFA-treated mice and untreated controls 12 h after K. pneumoniae infection. Scale bars, 50 μm. (d) Phagocytic capacity of isolated alveolar macrophages from SCFA-treated mice and untreated controls. (e) Bacterial loads of isolated alveolar macrophages from SCFA-treated mice and untreated controls. (f, g) Phagocytosis (f) and clearance (g) of SCFA-treated differentiated THP-1 cells and untreated controls after K. pneumoniae infection. (h) Survival rates of antibiotic-treated mice treated with SCFAs or vehicle. (i) Pulmonary bacterial burdens in antibiotic-treated mice treated with SCFAs or vehicle. The group size was 8 to 12 mice. Data are from three independent experiments (b, d to g, i) or one experiment representative of three independent experiments (a, c, h) (means ± SEM). The P values were determined using a log rank (Mantel-Cox) test (a, h) or two-tailed Student t tests (b to g, i). *, P < 0.05; **, P < 0.01; ***, P < 0.001.CC BY · PubMed Central
FIG 4 Gut microbiota depletion alters alveolar macrophage transcriptome profiles. (a) Hierarchical clustering heatmap of selected significant differentially expressed genes (DEGs) in alveolar macrophages from antibiotic-treated and untreated controls. Red denotes increased expression; green denotes decreased expression. (b) Selected examples of KEGG pathway enrichment. The defense response to bacteria, antimicrobial effector production, and the MAPK/ROS signaling pathway are highlighted in red. (c) Validation of Tnf-α, Ccl5, Il-1β, Cxcl1, and S100a9 mRNA expression using RT-qPCR. (d) Venn diagram of differentially expressed genes among four groups. (e) Responsiveness of shRNA-mediated Lamtor2 knockdown RAW264.7 cells and controls in terms of cytokine and chemokine production against K. pneumoniae infection. The group size was 8 to 12 mice. Data are from three independent experiments (c, e). The P values were determined using the hypergeometric test and Benjamini-Hochberg FDR correction (b) or two-tailed Student t tests (c, e). ***, P < 0.001. NS, not significant; AT, antibiotic-treated mice.
FIG 4 Gut microbiota depletion alters alveolar macrophage transcriptome profiles. (a) Hierarchical clustering heatmap of selected significant differentially expressed genes (DEGs) in alveolar macrophages from antibiotic-treated and untreated controls. Red denotes increased expression; green denotes decreased expression. (b) Selected examples of KEGG pathway enrichment. The defense response to bacteria, antimicrobial effector production, and the MAPK/ROS signaling pathway are highlighted in red. (c) Validation of Tnf-α, Ccl5, Il-1β, Cxcl1, and S100a9 mRNA expression using RT-qPCR. (d) Venn diagram of differentially expressed genes among four groups. (e) Responsiveness of shRNA-mediated Lamtor2 knockdown RAW264.7 cells and controls in terms of cytokine and chemokine production against K. pneumoniae infection. The group size was 8 to 12 mice. Data are from three independent experiments (c, e). The P values were determined using the hypergeometric test and Benjamini-Hochberg FDR correction (b) or two-tailed Student t tests (c, e). ***, P < 0.001. NS, not significant; AT, antibiotic-treated mice.CC BY · PubMed Central
FIG 5 SCFAs facilitate ERK activation by upregulating LAMTOR2. (a, b) Bacterial loads (a) and phagocytic capacity (b) of Lamtor2−/− RAW264.7 cells and controls after K. pneumoniae infection. (c) Immunofluorescence analysis of the uptake of K. pneumoniae in Lamtor2−/− RAW264.7 cells and controls. Arrows indicate K. pneumoniae. Scale bars, 10 μm. (d, left) Immunofluorescence analysis of colocalization between phagosomes and lysosome. (Right) Count of phagosomes localized with LAMP1-stained lysosome. Arrows indicate K. pneumoniae. Scale bars, 10 μm. (e) Immunoblot analysis of phosphorylated (p-) ERK and iNOS expression levels in Lamtor2−/− RAW264.7 cells and controls 6 h after K. pneumoniae infection (MOI = 10). (f) RT-qPCR analysis of Tnf-α, Il-6, Il-1β, Mcp-1, and Cxcl1 mRNA expression in Lamtor2−/− RAW264.7 cells and controls 6 h after K. pneumoniae infection (MOI = 10). (g) RT-qPCR analysis of Lamtor2 mRNA expression in SCFA-treated RAW264.7 cells after K. pneumoniae infection (MOI = 10). (h) Responsiveness of isolated alveolar macrophages from SCFA-treated mice and untreated controls to K. pneumoniae in terms of cytokine and chemokine production in vitro (MOI = 10). (i, j) Phagocytosis (i) and clearance (j) of SCFA-treated Gpr43−/− RAW264.7 cells and controls. (k) RT-qPCR analysis of Lamtor2, Tnf-α, and Il-1β mRNA expression in Gpr43−/− RAW264.7 cells and controls, both of which were incubated with SCFAs. (l) Immunoblot analysis of pERK, p-JNK, p-p38, and iNOS expression levels in RAW264.7 cells treated with SCFAs and controls after 6 h of K. pneumoniae infection. (m) Immunoblot analysis of pERK and iNOS in Gpr43−/− and Gpr43−/− Lamtor2 overexpression (OE) RAW264.7 cells incubated with SCFAs 6 h after K. pneumoniae infection. The group size was 8 to 12 mice. Data are from three independent experiments (a, b, f to k) or one experiment representative of three independent experiments (c, d, e, l, m) (means ± SEM). The P values were determined using two-tailed Student t tests (a, b, d, f to k). *, P < 0.05; **, P < 0.01; ***, P < 0.001. NS, not significant; WT, wild type.
FIG 5 SCFAs facilitate ERK activation by upregulating LAMTOR2. (a, b) Bacterial loads (a) and phagocytic capacity (b) of Lamtor2−/− RAW264.7 cells and controls after K. pneumoniae infection. (c) Immunofluorescence analysis of the uptake of K. pneumoniae in Lamtor2−/− RAW264.7 cells and controls. Arrows indicate K. pneumoniae. Scale bars, 10 μm. (d, left) Immunofluorescence analysis of colocalization between phagosomes and lysosome. (Right) Count of phagosomes localized with LAMP1-stained lysosome. Arrows indicate K. pneumoniae. Scale bars, 10 μm. (e) Immunoblot analysis of phosphorylated (p-) ERK and iNOS expression levels in Lamtor2−/− RAW264.7 cells and controls 6 h after K. pneumoniae infection (MOI = 10). (f) RT-qPCR analysis of Tnf-α, Il-6, Il-1β, Mcp-1, and Cxcl1 mRNA expression in Lamtor2−/− RAW264.7 cells and controls 6 h after K. pneumoniae infection (MOI = 10). (g) RT-qPCR analysis of Lamtor2 mRNA expression in SCFA-treated RAW264.7 cells after K. pneumoniae infection (MOI = 10). (h) Responsiveness of isolated alveolar macrophages from SCFA-treated mice and untreated controls to K. pneumoniae in terms of cytokine and chemokine production in vitro (MOI = 10). (i, j) Phagocytosis (i) and clearance (j) of SCFA-treated Gpr43−/− RAW264.7 cells and controls. (k) RT-qPCR analysis of Lamtor2, Tnf-α, and Il-1β mRNA expression in Gpr43−/− RAW264.7 cells and controls, both of which were incubated with SCFAs. (l) Immunoblot analysis of pERK, p-JNK, p-p38, and iNOS expression levels in RAW264.7 cells treated with SCFAs and controls after 6 h of K. pneumoniae infection. (m) Immunoblot analysis of pERK and iNOS in Gpr43−/− and Gpr43−/− Lamtor2 overexpression (OE) RAW264.7 cells incubated with SCFAs 6 h after K. pneumoniae infection. The group size was 8 to 12 mice. Data are from three independent experiments (a, b, f to k) or one experiment representative of three independent experiments (c, d, e, l, m) (means ± SEM). The P values were determined using two-tailed Student t tests (a, b, d, f to k). *, P < 0.05; **, P < 0.01; ***, P < 0.001. NS, not significant; WT, wild type.CC BY · PubMed Central
FIG 6 Lamtor2 loss of function leads to a decreased antimicrobial activity in vivo. (a) Survival rates of Lamtor2fl/fl Lyz2-Cre+ and littermate Lamtor2fl/fl mice intranasally infected with K. pneumoniae. (b) Pulmonary bacterial burdens of Lamtor2fl/fl Lyz2-Cre+ mice and controls 12 h and 24 h after K. pneumoniae infection. (c) Representative H&E staining and quantification of pathological scores of lung sections from Lamtor2fl/fl Lyz2-Cre+ mice and controls 12 h after K. pneumoniae infection. Scale bars, 50 μm. (d) Bacterial loads of isolated alveolar macrophages from Lamtor2fl/fl Lyz2-Cre+ mice and controls after K. pneumoniae infection. Scale bars, 20 μm. (e) Phagocytic capacity of isolated alveolar macrophages from Lamtor2fl/fl Lyz2-Cre+ mice and controls after K. pneumoniae infection. (f) Responsiveness of isolated alveolar macrophages from Lamtor2fl/flLyz2-Cre+ mice and controls to K. pneumoniae in terms of TNF-α, IL-6, 1L-1β, MCP-1, and CXCL1 production. (g) Bacterial loads of isolated alveolar macrophages from Lamtor2fl/fl Lyz2-Cre+ mice and controls treated with SCFAs after K. pneumoniae infection. The group size was 8 to 12 mice. Data are from three independent experiments (b, d to g) or one experiment representative of three independent experiments (a, c) (means ± SEM). The P values were determined using a log rank (Mantel-Cox) test (a), two-tailed Student t tests (b to f), or one-way ANOVA for multiple comparisons (g). *, P < 0.05; **, P < 0.01; ***, P < 0.001.
FIG 6 Lamtor2 loss of function leads to a decreased antimicrobial activity in vivo. (a) Survival rates of Lamtor2fl/fl Lyz2-Cre+ and littermate Lamtor2fl/fl mice intranasally infected with K. pneumoniae. (b) Pulmonary bacterial burdens of Lamtor2fl/fl Lyz2-Cre+ mice and controls 12 h and 24 h after K. pneumoniae infection. (c) Representative H&E staining and quantification of pathological scores of lung sections from Lamtor2fl/fl Lyz2-Cre+ mice and controls 12 h after K. pneumoniae infection. Scale bars, 50 μm. (d) Bacterial loads of isolated alveolar macrophages from Lamtor2fl/fl Lyz2-Cre+ mice and controls after K. pneumoniae infection. Scale bars, 20 μm. (e) Phagocytic capacity of isolated alveolar macrophages from Lamtor2fl/fl Lyz2-Cre+ mice and controls after K. pneumoniae infection. (f) Responsiveness of isolated alveolar macrophages from Lamtor2fl/flLyz2-Cre+ mice and controls to K. pneumoniae in terms of TNF-α, IL-6, 1L-1β, MCP-1, and CXCL1 production. (g) Bacterial loads of isolated alveolar macrophages from Lamtor2fl/fl Lyz2-Cre+ mice and controls treated with SCFAs after K. pneumoniae infection. The group size was 8 to 12 mice. Data are from three independent experiments (b, d to g) or one experiment representative of three independent experiments (a, c) (means ± SEM). The P values were determined using a log rank (Mantel-Cox) test (a), two-tailed Student t tests (b to f), or one-way ANOVA for multiple comparisons (g). *, P < 0.05; **, P < 0.01; ***, P < 0.001.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 63 references

Cited by

See all 83

Metadata

Authors
Wu, T., Li, H., Su, C., Xu, F., Yang, G., Sun, K., Xu, M., Lv, N., Meng, B., Liu, Y., Hu, L., Liu, Y., Gao, Y., Wang, H., Lan, Y., Xu, D., & Li, J.
Affiliations
  • First Affiliated Hospital of Anhui Medical University (CN)
  • Central South University (CN)
  • Anhui Medical University (CN)
  • Laboratory of Environmental Toxicology, Department of Toxicology, Anhui Medical University, Hefei, Anhui, China
Corresponding author
  • Lan, Yanhu
  • Li, Jiabin
Venue
mSystems
Published
2020-12-22
Volume
5
Issue
6
ISSN
2379-5077 (ISSN-L)
OpenAlex
W3096965223
Cited by
78
References
63
Citations by year
2026: 9 · 2025: 20 · 2024: 13 · 2023: 15 · 2022: 9 · 2021: 12
FWCI
2.92
Type
journal article
Language
en
Open access
Licence
Locations
  • mSystems (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China (81973983, 81673242)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords
short-chain fatty acids, gut microbiota, macrophages, Klebsiella pneumoniae, bacterial clearance, immune response, pneumonia, gut-lung axis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Microbiota-Derived Short-Chain Fatty Acids Promote LAMTOR2-Mediated Immune Responses in Macrophages. https://app.cochat.ai/papers/10.1128/msystems.00587-20
The paper
Wu, T., Li, H., Su, C., Xu, F., Yang, G., Sun, K., Xu, M., Lv, N., Meng, B., Liu, Y., Hu, L., Liu, Y., Gao, Y., Wang, H., Lan, Y., Xu, D., & Li, J. (2020). Microbiota-Derived Short-Chain Fatty Acids Promote LAMTOR2-Mediated Immune Responses in Macrophages. mSystems. https://doi.org/10.1128/msystems.00587-20

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.